Generic, radical technology is of interest because of its potential for value creation across a broad range of industries and applications. Advanced materials ventures are attracted by this opportunity yet face intensified challenges in commercializing technology of this kind as upstream entrants into distinct established value chains. In this paper, we build on Freeman's concept of technological innovation as a technological and market matching process to develop a new model of the variables influencing value creation by advanced materials ventures. We then demonstrate the model using evidence from a sample of 10 US advanced materials ventures, including an in-depth case study exemplar. From the literature, our model, and our case study observation, we construct four propositions concerning the success of advanced materials ventures in commercializing radical technology.

Clusters, Small firm growth, New technology-based firms, Gibrat’s Law, Economic geography, R1, L2, L26, M2,

No abstract

No abstract

Internal corporate venturing enables radical innovation within established firms in mature markets. Without effectively designed and managed internal corporate ventures, the organizational constraints of established firms will strongly favour incremental innovation over radical innovation. This paper investigates the evolution of a successful internal corporate venture within a large, incumbent chemical firm, now known as Evonik Degussa, to reveal the challenges, organizational design, and management strategies of their commercialization of radical nanomaterials technology. The commercialization of nanomaterials technology is of great interest to incumbent materials and chemical firms and to independent ventures, but the radical, generic, and capital intensive nature of nanomaterials technology requires organizational and managerial innovation. This case study demonstrates a model to enable growth through radical innovation in nanomaterials, while taking advantage of an incumbent firm's capabilities and complementary assets. Organizational strategies include incubation from a risk-adverse culture, relatively long timelines for evaluation, and a high-level steering committee. Managerial strategies focus on product development, risk reduction, and active risk management.